Nervgen Pharma Corp.
NGEN Nasdaq· Pharmaceutical Preparations
KIRA · Stoqly’s AI analyst, in plain words
- Nervgen Pharma Corp. lost $31.6M in fiscal 2025.
Market cap
—
P/E
—
Revenue
—
Net income
−$31.6M
Free cash flow
—
Operating margin
—
Nervgen Pharma Corp. in 30 seconds · fiscal 2025
Does it make a profit?
−$31.6M
No. It lost money last year.
What Nervgen Pharma Corp. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 40-F · Mar 31, 2026
- Legal name
- NERVGEN PHARMA CORP.
- CIK
- 0001751912
Nervgen Pharma Corp. · NGEN
Results and finances
The last 2 fiscal years. Amounts in USD.
| Fiscal year | FY24 | FY25 |
|---|---|---|
| Sales and profit | ||
| Net income | −$17.7M | −$31.6M |
| Diluted EPS | −$0.26 | −$0.44 |
| Cash | ||
| Cash from operations | −$12.3M | −$13.9M |
| Share count change | — | 7.4% |
| Debt and strength | ||
| Cash and short-term investments | $12.0M | $16.1M |
| Shareholders' equity | $1.8M | $2.5M |
| Current ratio | 1.1x | 1.2x |
| Returns and quality | ||
| Return on equity | −988.5% | −1,457.4% |
| Return on tangible equity | −1,206.2% | −1,408.3% |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Nervgen Pharma Corp. · NGEN
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Source: SEC EDGAR XBRL filings (CIK 0001751912). Data updated October 24, 2026. Filed in CAD under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only — not investment advice. Check the original filings before relying on any figure.